Microglia and mast cells: two tracks on the road to neuroinflammation - PubMed (original) (raw)

Review

. 2012 Aug;26(8):3103-17.

doi: 10.1096/fj.11-197194. Epub 2012 Apr 19.

Affiliations

• PMID: 22516295
• DOI: 10.1096/fj.11-197194

Review

Microglia and mast cells: two tracks on the road to neuroinflammation

Stephen D Skaper et al. FASEB J. 2012 Aug.

Abstract

One of the more important recent advances in neuroscience research is the understanding that there is extensive communication between the immune system and the central nervous system (CNS). Proinflammatory cytokines play a key role in this communication. The emerging realization is that glia and microglia, in particular, (which are the brain's resident macrophages), constitute an important source of inflammatory mediators and may have fundamental roles in CNS disorders from neuropathic pain and epilepsy to neurodegenerative diseases. Microglia respond also to proinflammatory signals released from other non-neuronal cells, principally those of immune origin. Mast cells are of particular relevance in this context. These immunity-related cells, while resident in the CNS, are capable of migrating across the blood-spinal cord and blood-brain barriers in situations where the barrier is compromised as a result of CNS pathology. Emerging evidence suggests the possibility of mast cell-glia communications and opens exciting new perspectives for designing therapies to target neuroinflammation by differentially modulating the activation of non-neuronal cells normally controlling neuronal sensitization, both peripherally and centrally. This review aims to provide an overview of recent progress relating to the pathobiology of neuroinflammation, the role of microglia, neuroimmune interactions involving mast cells, in particular, and the possibility that mast cell-microglia crosstalk may contribute to the exacerbation of acute symptoms of chronic neurodegenerative disease and accelerate disease progression, as well as promote pain transmission pathways. We conclude by considering the therapeutic potential of treating systemic inflammation or blockade of signaling pathways from the periphery to the brain in such settings.

PubMed Disclaimer

Similar articles

• Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.
  Skaper SD, Facci L. Skaper SD, et al. Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3312-25. doi: 10.1098/rstb.2011.0391. Philos Trans R Soc Lond B Biol Sci. 2012. PMID: 23108549 Free PMC article. Review.
• Mast cells, glia and neuroinflammation: partners in crime?
  Skaper SD, Facci L, Giusti P. Skaper SD, et al. Immunology. 2014 Mar;141(3):314-27. doi: 10.1111/imm.12170. Immunology. 2014. PMID: 24032675 Free PMC article. Review.
• Mast cells and neuroinflammation.
  Dong H, Zhang X, Qian Y. Dong H, et al. Med Sci Monit Basic Res. 2014 Dec 21;20:200-6. doi: 10.12659/MSMBR.893093. Med Sci Monit Basic Res. 2014. PMID: 25529562 Free PMC article. Review.
• Neuronal injury in chronic CNS inflammation.
  Zindler E, Zipp F. Zindler E, et al. Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29. Best Pract Res Clin Anaesthesiol. 2010. PMID: 21619866 Review.
• The function of microglia through purinergic receptors: neuropathic pain and cytokine release.
  Inoue K. Inoue K. Pharmacol Ther. 2006 Jan;109(1-2):210-26. doi: 10.1016/j.pharmthera.2005.07.001. Epub 2005 Sep 19. Pharmacol Ther. 2006. PMID: 16169595 Review.

Cited by

• Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis.
  Zhang X, Dong H, Li N, Zhang S, Sun J, Zhang S, Qian Y. Zhang X, et al. J Neuroinflammation. 2016 May 31;13(1):127. doi: 10.1186/s12974-016-0592-9. J Neuroinflammation. 2016. PMID: 27245661 Free PMC article.
• Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approaches.
  Fuster-Matanzo A, Llorens-Martín M, Hernández F, Avila J. Fuster-Matanzo A, et al. Mediators Inflamm. 2013;2013:260925. doi: 10.1155/2013/260925. Epub 2013 Apr 3. Mediators Inflamm. 2013. PMID: 23690659 Free PMC article. Review.
• A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists.
  Soni S, Lukhey MS, Thawkar BS, Chintamaneni M, Kaur G, Joshi H, Ramniwas S, Tuli HS. Soni S, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):4643-4656. doi: 10.1007/s00210-024-02994-z. Epub 2024 Feb 13. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38349395 Review.
• Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis.
  Trias E, Ibarburu S, Barreto-Núñez R, Babdor J, Maciel TT, Guillo M, Gros L, Dubreuil P, Díaz-Amarilla P, Cassina P, Martínez-Palma L, Moura IC, Beckman JS, Hermine O, Barbeito L. Trias E, et al. J Neuroinflammation. 2016 Jul 11;13(1):177. doi: 10.1186/s12974-016-0620-9. J Neuroinflammation. 2016. PMID: 27400786 Free PMC article.
• Role of Metabotropic Glutamate Receptors in Neurological Disorders.
  Crupi R, Impellizzeri D, Cuzzocrea S. Crupi R, et al. Front Mol Neurosci. 2019 Feb 8;12:20. doi: 10.3389/fnmol.2019.00020. eCollection 2019. Front Mol Neurosci. 2019. PMID: 30800054 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley